Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice

BACKGROUND: Gastrointestinal harm, known to occur with NSAIDs, is thought to be lower with NSAID and gastroprotective agent, and with inhibitors selective to cyclooxygenase-2 (coxibs) at usual plasma concentrations. We examine competing strategies for available evidence of reduced gastrointestinal b...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, R Andrew, Derry, Sheena, Phillips, Ceri J, McQuay, Henry J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626078/
https://www.ncbi.nlm.nih.gov/pubmed/17054784
http://dx.doi.org/10.1186/1471-2474-7-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626078/
https://www.ncbi.nlm.nih.gov/pubmed/17054784
http://dx.doi.org/10.1186/1471-2474-7-79

Ejemplares similares